Autopsy report · NCT01321866

Cutting Balloon Versus Non-cutting Balloon for the Treatment of Venous Stenosis in the Fistulas of Hemodialyzed Patients

“Inclusion curve too slow.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 1 year 2 months before it started.
• Ran for about 3 years 7 months before it stopped.
• 42 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Centre Hospitalier Universitaire de Nīmes

Sponsor type

University, hospital or other

Conditions

Arteriovenous Fistula; Fistula

Interventions

Cutting balloon angioplasty; Angioplasty

Participants

42

Sites

1

Countries

France

Trials that died the same way

• Relapse Prevention With Escitalopram or Nortriptyline Following Electro-Convulsive Treatment (DUAG-7)
  “Slow inclusion” (77% match in meaning)
• PET / CT With 18F-FDG: Does it Optimize the I 123-MIBG Imaging Results in the Search for Discriminating Factors for the Implementation of an Implantable Defibrillator?
  “Inclusion rate too slow / infeasible.” (70% match in meaning)
• Risk of Rupture of Aneurysms of the Thoracic Ascending Aorta (ATA) From the Dynamic Imaging
  “low inclusion rates” (61% match in meaning)
• The Influence of Pneumoperitoneum on Minimal Invasive Cardiac Output Measurements
  “Low inclusion rate” (61% match in meaning)
• Respiratory Variations for Assessing Blood Withdrawal 2
  “insufficient inclusion rate” (60% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.